The big type 1 diabetes foundation JDRF this week launched a new financial vehicle to more nimbly invest in companies developing medicines or devices for type 1 diabetes.
The JDRF T1D Fund, as the vehicle is being called, launches with $42 million and aims to raise $80 million in its first two years. The new fund will focus on opportunities toward the later stages of product development. It will often take equity stakes in companies, or negotiate a share of future product royalties.
About the Author Reprints
